Comparison of efficacy and safety between aspirin and oral anticoagulants for venous thromboembolism prophylaxis after major orthopaedic surgery: a meta-analysis of randomized clinical trials
Vergleich von Wirksamkeit und Sicherheit zwischen Aspirin und oralen Antikoagulanzien zur VTE-Prophylaxe nach großer orthopädischer Operation: Metaanalyse randomisierter klinischer Studien
Frontiers in Pharmacology · 08.01.2024 · 14
DOI: 10.3389/fphar.2023.1326224 ↗Auf einen Blick
12 RCTs zeigen: Aspirin war nach großer orthopädischer Operation mit mehr VTE verbunden als orale Antikoagulanzien, senkte aber Blutungsereignisse.
Fragestellung
Wie wirksam und sicher ist Aspirin im Vergleich zu oralen Antikoagulanzien zur VTE-Prophylaxe nach THA, TKA oder HFS?
Methode
Systematische Übersicht und Metaanalyse von RCTs; Suche in PubMed, Embase, Web of Science, Cochrane Library und ClinicalTrials.gov bis 20. Juli 2023; Verzerrungsrisiko nach Cochrane.
Ergebnisse
12 RCTs mit 5.088 Teilnehmenden. VTE: RR 1,206 (95 %-KI 1,053–1,383) zugunsten der oralen Antikoagulanzien. Keine signifikanten Unterschiede bei major bleeding, Mortalität und Wundereignissen; weniger minor bleeding und Gesamtblutungen unter Aspirin.
Einschränkungen
Die Studien in der Warfarin-Gruppe wurden alle vor 2000 durchgeführt; die Ergebnisse müssen weiter bestätigt werden.
Schlussfolgerung der Autor:innen
Aspirin reduziert im Vergleich zu oralen Antikoagulanzien das Blutungsrisiko nach großer orthopädischer Operation, kann aber die VTE-Prophylaxe teilweise beeinträchtigen.
Kernaussagen
- Mehr VTE unter Aspirin: RR 1,206 (95 %-KI 1,053–1,383)
- Weniger minor bleeding und Gesamtblutungen unter Aspirin
- Warfarin-Daten stammen aus Studien vor 2000
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 08.01.2024. Verfasst von Xingyue Zheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Personalized Drug Therapy Key Laboratory of Sichuan Province, School of Medicine, University of Electronic Science and Technology of China, Chengdu, …. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Sichuan Province.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Background: venous thromboembolism (VTE) is one of the most common complications after major orthopaedic surgery. Recent studies have suggested that aspirin may also be effective in preventing VTE, but it is still controversial whether it can be routinely used.
Objectives
To compare the efficacy and safety of aspirin against oral anticoagulants in the prevention of VTE following total hip arthroplasty (THA), total knee arthroplasty (TKA) or hip fracture surgery (HFS).
Methods
Relevant publications have been obtained using electronic search databases such as PubMed, Embase, Web of Science, Cochrane Library, and Clinical Trials. gov. from inception to 20 July 2023. Only RCTs evaluating the efficacy and safety of aspirin compared with oral anticoagulants undergoing major orthopaedic surgery were included in the meta-analysis. The primary outcome reported was any VTE event (including deep vein thrombosis (DVT) and pulmonary embolism (PE)). Secondary outcomes included mortality, major bleeding (including gastrointestinal bleed, cerebrovascular hemorrhage, or any bleeding requiring a return to the theater), minor bleeding (ecchymosis, epistaxis, hematuria), and wound complications. The risk of bias for all included studies was assessed according to the Cochrane Collaboration’s tool.
Results
After screening 974 studies, 12 randomized clinical trials (RCTs) were included, involving 5,088 participants, including 2,540 participants in aspirin, 2,205 participants in rivaroxaban, and 323 participants in warfarin. Aspirin was found to be less effective than oral anticoagulants in thromboprophylaxis after major orthopedic surgery (RR = 1.206, 95% CI 1.053–1.383). After subgroup analysis according to the type of oral anticoagulant, the results showed that aspirin was similar to rivaroxaban and inferior to warfarin. Considering that the studies in the warfarin group were all conducted before 2000, our results need to be further confirmed. In addition, the aspirin group had a higher risk of VTE than the control group in other subgroups, including a follow-up time of ≤3 months, type of procedure as TKA, high-dose aspirin (≥650 mg qd), and no combined use of mechanical prophylaxis. In terms of safety events, aspirin did not show significant differences in major bleeding (RR = 0.952, 95% CI 0.499–1.815), all-cause mortality (RR = 1.208, 95% CI 0.459–3.177), and wound-related events (RR = 0.618, 95% CI 0.333–1.145) compared with oral anticoagulants, and aspirin was associated with a reduction in the risk of minor bleeding (RR = 0.685, 95% CI 0.552–0.850) events and total bleeding (RR = 0.726, 95% CI 0.590–0.892).
Conclusion
Aspirin reduces bleeding risk after major orthopedic surgery compared with oral anticoagulants, but may sacrifice VTE prevention to some extent. Updated evidence is needed to analyze the thromboprophylaxis effects of aspirin in patients undergoing major orthopedic surgery. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=463481 , identifier CRD42023463481.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Personalized Drug Therapy Key Laboratory of Sichuan Province, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
- Department of Pharmacy, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
- Department of Pharmacy, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China.
Förderung
- National Key Research and Development Program of China
- Natural Science Foundation of Sichuan Province
Zitieren
APA
Zheng, X., Nong, L., Song, Y., Han, L., Zhang, Y., Yin, Q., & Bian, Y. (2024). Comparison of efficacy and safety between aspirin and oral anticoagulants for venous thromboembolism prophylaxis after major orthopaedic surgery: a meta-analysis of randomized clinical trials. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1326224
Vancouver
Zheng X, Nong L, Song Y, Han L, Zhang Y, Yin Q, et al. Comparison of efficacy and safety between aspirin and oral anticoagulants for venous thromboembolism prophylaxis after major orthopaedic surgery: a meta-analysis of randomized clinical trials. Frontiers in Pharmacology. 2024;14. doi:10.3389/fphar.2023.1326224
BibTeX
@article{Zheng2024,
author = {Zheng, Xingyue and Nong, Li and Song, Yujie and Han, Lizhu and Zhang, Yuan and Yin, Qinan and Bian, Yuan},
title = {Comparison of efficacy and safety between aspirin and oral anticoagulants for venous thromboembolism prophylaxis after major orthopaedic surgery: a meta-analysis of randomized clinical trials},
journal = {Frontiers in Pharmacology},
year = {2024},
volume = {14},
doi = {10.3389/fphar.2023.1326224}
}
EUVIMED